We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 24, 2022

Potential Benefits of Metabolic Surgery in Patients With SIRD

The Lancet Diabetes & Endocrinology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Diabetes & Endocrinology
Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study
Lancet Diabetes Endocrinol 2022 Feb 08;[EPub Ahead of Print], V Raverdy, RV Cohen, R Caiazzo, H Verkindt, TBZ Petry, C Marciniak, B Legendre, P Bauvin, E Chatelain, A Duhamel, E Drumez, N Oukhouya-Daoud, M Chetboun, G Baud, E Ahlqvist, N Wierup, O Asplund, B Laferrère, L Groop, F Pattou

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading